Jazz Pharmaceuticals Buys GW Pharma For $7.2 Billion
(Video length 00:00:56)
Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC’s Becky Quick reports.
(Video length 00:00:56)
Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC’s Becky Quick reports.